ANODE

ANODE: prophylactic ANtibiotics for the prevention of infection following Operative DElivery.

Recruitment
Total
3427
Target
3424

Recruitment to the ANODE trial is closed.
We would like to thank all the families and site staff who took part.

What is the purpose of the study?

Currently mothers are not routinely given antibiotics after a forceps or ventouse delivery. The aim of this study is to find out if giving mothers a single dose of antibiotics is effective at preventing infection after forceps or ventouse deliveries. There are concerns about over prescribing antibiotics but infections can be very serious, so this is an important question to answer. We really don’t know if giving a single dose of antibiotics makes a difference.

General Information

EudraCT No.:
2015-000872-89
REC Reference:
15/SC/0442
ISRCTN:
11166984
Clinical Trials Unit:
National Perinatal Epidemiology Unit CTU
Sponsor:
University of Oxford
Funder:
NIHR Health Technology Assessment (HTA) Programme
Recruitment Target:
3,424 (28 month recruitment period)
Duration of Study:
March 2015 - January 2019

 

ANODE News

No recent news. See older news.

This study is funded by the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme (Reference Number 13/96/07). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.